Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free public preview Track PAYP with free AI briefings, catalyst countdowns, and dilution alerts.
Create Free Account → Log in

PAYP

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$123.6B Cash on Hand
CF+ Cash Runway
7.3% Short Interest

💰 Cash Runway & Dilution Risk

PAYP holds $123.6B in cash and its operations are currently cash-flow neutral or positive.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for PAYP free →

Get the full PAYP picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for PAYP and 2 more tickers of your choice.

Create Free Account →
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.